Determined appropriate valuation for bid by utilizing DCF analysis and confirming with publicly traded metrics.
Provided structural changes to transaction to maximize returns and increase probability of closing.
Served as a key contributor for a project team to acquire and transform existing facilities into state-of-the-art treatment facilities. Pursued a $550M funding commitment.
Researched market opportunities and applied investment framework to new market sectors.
Initiated and monitored large merger arbitrage positions including regular risk reviews.
Led strategic financial decision evaluations including acquisitions, divestitures, new business ventures, and investment/capital budgeting analyses for both regulated and non-regulated business segments.
Conducted audits and due diligence reviews of internal company operations, external contracts, subsidiaries, and potential acquisition targets.
Developed and delivered presentations illustrating complex transaction terms to all levels of management, including Board of Directors.
